Gao H Y, Xu J L, Meng H X, He L, Hou J X
Department of Periodontology, Peking University School and Hospital of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China.
Department of Periodontology, School and Hospital of Stomatology, Tianjin Medical University, Tianjin 300070, China.
Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Aug 18;52(4):750-754. doi: 10.19723/j.issn.1671-167X.2020.04.029.
To compare the blood parameters related to erythrocyte and platelet between baseline and 3 months after initial periodontal therapy in patients with both type 2 diabetes mellitus and chronic periodontitis (DM-P).
According to the International Symposium on Classification of Periodontal Diseases and Conditions in 1999 and the diagnostic criteria of type 2 diabetes mellitus proposed by the World Health Organization in 1999, 35 patients with DM-P were recruited. All the participants received initial periodontal therapy, including oral hygiene instruction, scaling, and root planning provided by one senior periodontist. Original diet, exercise, and medication for blood glucose control were unchanged for all the participants. At baseline and 3 months after initial periodontal therapy, the clinical periodontal parameters, including probing depth (PD), bleeding index (BI) and clinical attachment loss (CAL); erythrocyte-related indexes, including red blood cell (RBC) count, hemoglobin (HGB), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), RBC volume distribution width (RDW); platelet-related indexes, including platelet (PLT) count, mean platelet volume (MPV), platelet distribution width (PDW), plateletocrit (PCT) were measured and compared.
Compared with baseline, the periodontal parameters, including PD [(3.370±0.601) mm (2.729±0.431) mm], BI [2.160 (1.5503.410) 1.420 (1.0002.970)] and CAL [(3.307±1.577) mm (2.990±1.587) mm], were significantly reduced ( < 0.001) three months after the initial periodontal therapy; the erythrocyte-related indexes, including RBC count [(4.727±0.392)×10/L (4.825±0.394)×10/L, =0.010], HGB [(145.886±11.792) g/L (149.200±12.979) g/L, =0.007] and HCT [43.40% (37.50%48.50%) 43.80% (38.50%53.20%), =0.003], were significantly increased three months after the initial periodontal therapy; PLT count [(216.714±61.900)×10/L (205.886±62.051)×10/L, =0.016] was significantly reduced 3 months after the initial periodontal therapy.
The initial periodontal therapy can significantly improve blood parameters related to RBC and PLT, which might decrease the risk of vascular complications in DM-P patients.
比较2型糖尿病合并慢性牙周炎(DM-P)患者在初始牙周治疗前及治疗3个月后的红细胞和血小板相关血液参数。
根据1999年牙周疾病和状况分类国际研讨会以及世界卫生组织1999年提出的2型糖尿病诊断标准,招募了35例DM-P患者。所有参与者均接受了初始牙周治疗,包括由一位资深牙周病医生提供的口腔卫生指导、洁治和根面平整。所有参与者的原始饮食、运动和血糖控制药物均未改变。在基线时以及初始牙周治疗后3个月,测量并比较临床牙周参数,包括探诊深度(PD)、出血指数(BI)和临床附着丧失(CAL);红细胞相关指标,包括红细胞(RBC)计数、血红蛋白(HGB)、血细胞比容(HCT)、平均红细胞体积(MCV)、平均红细胞血红蛋白含量(MCH)、平均红细胞血红蛋白浓度(MCHC)、红细胞体积分布宽度(RDW);血小板相关指标,包括血小板(PLT)计数、平均血小板体积(MPV)、血小板分布宽度(PDW)、血小板压积(PCT)。
与基线相比,初始牙周治疗3个月后,牙周参数,包括PD[(3.370±0.601)mm (2.729±0.431)mm]、BI[2.160(1.5503.410) 1.420(1.0002.970)]和CAL[(3.307±1.577)mm (2.990±1.587)mm]显著降低(<0.001);红细胞相关指标,包括RBC计数[(4.727±0.392)×10/L (4.825±0.394)×10/L,P = 0.010]、HGB[(145.886±11.792)g/L (149.200±12.979)g/L,P = 0.007]和HCT[43.40%(37.50%48.50%) 43.80%(38.50%53.20%),P = 0.003]显著升高;PLT计数[(216.714±61.900)×10/L (205.886±62.051)×10/L,P = 0.016]在初始牙周治疗3个月后显著降低。
初始牙周治疗可显著改善与红细胞和血小板相关的血液参数,这可能降低DM-P患者血管并发症的风险。